William J. Phillips

Ottawa, ON K1H8L6, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Epigenomic profiling links IGF2 overexpression to anthracycline resistance in colorectal cancer organoids.

Epigenomic profiling links IGF2 overexpression to anthracycline resistance in colorectal cancer organoids.

Journal: JCI insight

Published: July 20, 2026

Epigenomic profiling links IGF2 oveexpression to anthracycline resistance in colorectal cancer organoids.

Epigenomic profiling links IGF2 oveexpression to anthracycline resistance in colorectal cancer organoids.

Journal: JCI insight

Published: July 20, 2026

In the era of adjuvant alectinib, what can we learn from the E4512 trial of adjuvant crizotinib?

In the era of adjuvant alectinib, what can we learn from the E4512 trial of adjuvant crizotinib?

Journal: The Lancet. Respiratory medicine

Published: July 13, 2026

The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC.

The Prognostic Significance of EGFR Adjusted Variant Allele Frequency on First-Line Osimertinib Efficacy in Advanced EGFR-Mutant NSCLC.

Journal: Current oncology (Toronto, Ont.)

Published: June 16, 2026

Primary Nodal Poroid Hidradenocarcinoma With YAP1::NUTM1 Fusion: Report of a Rare Case.

Primary Nodal Poroid Hidradenocarcinoma With YAP1::NUTM1 Fusion: Report of a Rare Case.

Journal: Journal of cutaneous pathology

Published: May 14, 2026

A Response to the Letter to the Editor: Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets.

A Response to the Letter to the Editor: Supporting a Neuroprotective Effect of Lorlatinib Across ALK and ROS1 Targets.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 02, 2026

Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840].

Corrigendum to "Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)" [Lung Cancer 210 (2025) 108840].

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 17, 2025

Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers.

Hiding in Plain Sight: The Neuro-Protective Benefit of Tropomyosin Receptor Kinase Inhibition in Non-Neurotrophic Receptor Tyrosine Kinase-Driven Lung Cancers.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: December 15, 2025

Panorama of Chromosomal Instability in Lung Cancer.

Panorama of Chromosomal Instability in Lung Cancer.

Journal: medRxiv : the preprint server for health sciences

Published: September 29, 2025

Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE).

Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE).

Journal: Lung cancer (Amsterdam, Netherlands)

Published: April 17, 2025

Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres.

Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer Centres.

Journal: Current oncology (Toronto, Ont.)

Published: December 10, 2024

Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada.

Real-world evaluation of treatment patterns and clinical outcomes in patients with BRAF-V600E metastatic colorectal cancer (mCRC) in Canada.

Journal: Cancer treatment and research communications

Published: November 28, 2024

Showing 1-12 of 31

Last Updated: 09/26/2026